Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Dec 24 | BCRX BioCryst Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 7.39 | 6,096 | 45.05 k | 384,843 |
19 Dec 24 | BCRX BioCryst Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 125,950 | 0.00 | 390,939 |
19 Dec 24 | BCRX BioCryst Pharmaceuticals | Emp. Stock Option Common Stock | Grant | Acquire A | No | No | 7.39 | 260,950 | 1.93 mm | 260,950 |
14 Dec 24 | BCRX BioCryst Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 7.53 | 7,150 | 53.84 k | 264,989 |
14 May 24 | BCRX BioCryst Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 5.86 | 30,000 | 175.80 k | 272,139 |
31 Mar 24 | BCRX BioCryst Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 5.08 | 7,525 | 38.23 k | 242,139 |
12 Feb 24 | IMGN Immunogen | Common Stock | Sale back to company | Dispose D | No | No | 0 | 3,074 | 0.00 | 0 |
12 Feb 24 | IMGN Immunogen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 17.72 | 19,597 | 347.26 k | 0 |
12 Feb 24 | IMGN Immunogen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.37 | 32,066 | 108.06 k | 0 |
12 Feb 24 | IMGN Immunogen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.97 | 44,000 | 262.68 k | 0 |